Catalyst
Slingshot members are tracking this event:
GlaxoSmithKline (GSK) and Johnson & Johnson (JNJ) Submit Sirukumab in Treatment of Rheumatoid Arthritis to European Medicines Agency
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 12, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sirukumab, Rheumatoid Arthritis, European Medicines Agency, Marketing Application